trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wong CY et al. Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells. 2011 J. Biol. Chem. pmid:21636851
Min XJ et al. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells. 2011 Exp. Biol. Med. (Maywood) pmid:21454376
Belakavadi M et al. Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. 2011 Mol. Cell. Endocrinol. pmid:21458529
da Costa Prando E et al. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. 2011 Epigenetics pmid:22139571
Kang H and Roh S Extended exposure to trichostatin A after activation alters the expression of genes important for early development in nuclear transfer murine embryos. 2011 J. Vet. Med. Sci. pmid:21187677
Salvi V et al. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 2010 Sep-Oct Immunobiology pmid:20573419
Schuhmann NK et al. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors. 2010 Exp. Hematol. pmid:20447441
Hizume K et al. Nano-scale analyses of the chromatin decompaction induced by histone acetylation. 2010 Arch. Histol. Cytol. pmid:22572182
Mossman D et al. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. 2010 BMC Cancer pmid:20618997
Ma J et al. Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. 2010 Carcinogenesis pmid:20622005
Oliveira CS et al. Effects of histone hyperacetylation on the preimplantation development of male and female bovine embryos. 2010 Reprod. Fertil. Dev. pmid:20591338
Suo L et al. Changes in acetylation on lysine 12 of histone H4 (acH4K12) of murine oocytes during maternal aging may affect fertilization and subsequent embryo development. 2010 Fertil. Steril. pmid:19285668
Xia J et al. Epigenetic modification of vomeronasal (V2r) precursor neurons by histone deacetylation. 2010 Neuroscience pmid:20594945
Tian F et al. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. 2010 Ann. N. Y. Acad. Sci. pmid:20633124
Rössler R et al. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. 2010 Neuroscience pmid:20643196
Rahman R et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. 2010 Mol. Cancer Ther. pmid:20643785
Tong JH et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. 2010 BMC Cancer pmid:20525238
Han DS et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. 2010 J. Cell. Biochem. pmid:20568119
Trtkova K et al. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB. 2010 Neoplasma pmid:20568894
Legartova S et al. Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors. 2010 Neoplasma pmid:20568903
Kim J et al. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells. 2010 Mol. Cancer Ther. pmid:20571067
Obier N and Müller AM Chromatin flow cytometry identifies changes in epigenetic cell states. 2010 Cells Tissues Organs (Print) pmid:19776550
Fan J et al. Expression and function of CD9 in melanoma cells. 2010 Mol. Carcinog. pmid:19777564
Beedanagari SR et al. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. 2010 Toxicol. Lett. pmid:20116417
Lu Y et al. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. 2010 Hum. Reprod. pmid:20118114
Davies GF et al. Troglitazone inhibits histone deacetylase activity in breast cancer cells. 2010 Cancer Lett. pmid:19699029
Hajji N et al. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. 2010 Oncogene pmid:20118981
Suh HS et al. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. 2010 J Neuroimmune Pharmacol pmid:20157787
Crosson CE et al. Inhibition of histone deacetylase protects the retina from ischemic injury. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20164449
Jang ER et al. ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. 2010 Exp. Mol. Med. pmid:20164679
Desai D et al. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. 2010 Bioorg. Med. Chem. Lett. pmid:20167479
Ishimaru N et al. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. 2010 Biochem. Biophys. Res. Commun. pmid:20188708
Popova AP et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20190033
Calonge TM et al. Transformation/transcription domain-associated protein (TRRAP)-mediated regulation of Wee1. 2010 Genetics pmid:20194963
Fakhry H et al. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells. 2010 Hum. Pathol. pmid:20178884
Wood JP et al. A comparison of differentiation protocols for RGC-5 cells. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20181845
Das ZC et al. Lyophilized somatic cells direct embryonic development after whole cell intracytoplasmic injection into pig oocytes. 2010 Cryobiology pmid:20691649
Mercer TR et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. 2010 BMC Neurosci pmid:20137068
Wu J et al. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. 2010 Acta Pharmacol. Sin. pmid:20048748
Sonnemann J et al. Serine proteases in histone deacetylase inhibitor-induced apoptosis. 2010 Mol. Cancer Ther. pmid:20682651
Hebbel RP et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. 2010 Blood pmid:20053759
Fu J et al. Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. 2010 Bioorg. Med. Chem. pmid:21067930
He R et al. Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. 2010 J. Med. Chem. pmid:20055418
Nicodeme E et al. Suppression of inflammation by a synthetic histone mimic. 2010 Nature pmid:21068722
Ajiro K et al. Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo. 2010 Cell Death Differ. pmid:20057502
Auzzas L et al. Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity. 2010 J. Med. Chem. pmid:21073160
Choi YS et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. 2010 J. Cell. Mol. Med. pmid:20070436
Lee KJ et al. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. 2010 Biochim. Biophys. Acta pmid:20080132
Grabiec AM et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. 2010 J. Immunol. pmid:20100935
Chatterjee A et al. An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. 2010 Org. Lett. pmid:20104892
Kicic A et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. 2010 Am. J. Respir. Crit. Care Med. pmid:20110557
Su Y et al. Human RecQL4 helicase plays critical roles in prostate carcinogenesis. 2010 Cancer Res. pmid:21045146
Taura A et al. Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. 2010 Neuroscience pmid:20060033
Chou JL et al. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. 2010 Lab. Invest. pmid:20065949
Giles KE et al. Chromatin boundaries, insulators, and long-range interactions in the nucleus. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21047907
Chang J et al. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. 2010 World J. Gastroenterol. pmid:20066738
Huber K et al. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). 2010 J. Med. Chem. pmid:20030343
Kroening S et al. Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. 2010 Am. J. Physiol. Renal Physiol. pmid:20032117
Li Y et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. 2010 Mol. Cancer pmid:20946668
Gupta PK et al. Inhibitors selective for HDAC6 in enzymes and cells. 2010 Bioorg. Med. Chem. Lett. pmid:20947351
Song S et al. Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. 2010 Cardiovasc. Res. pmid:19633316
Eskeland R et al. Histone acetylation and the maintenance of chromatin compaction by Polycomb repressive complexes. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21502416
Shiau RJ et al. Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. 2010 Eur J Nutr pmid:19639378
Yuan GB et al. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells. 2010 Chin J Cancer pmid:20346212
Wang QH et al. Opposite effects of Trichostatin A on activation of mast cells by different stimulants. 2010 FEBS Lett. pmid:20371366
Simboeck E et al. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. 2010 J. Biol. Chem. pmid:20952396
Robertson DM et al. C-terminal cleavage of DeltaNp63alpha is associated with TSA-induced apoptosis in immortalized corneal epithelial cells. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20375332
Halili MA et al. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. 2010 J. Leukoc. Biol. pmid:20200406
Karagiannis TC et al. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. 2010 Aging (Albany NY) pmid:20930262
Reichrath S et al. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. 2010 J. Steroid Biochem. Mol. Biol. pmid:20206691
Milagre I et al. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2010 J. Alzheimers Dis. pmid:20930312
Bertrand P Inside HDAC with HDAC inhibitors. 2010 Eur J Med Chem pmid:20223566
Gao A et al. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. 2010 Toxicol. Lett. pmid:20230882
Majid S et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. 2010 Cancer Res. pmid:20332239
Khobta A et al. Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. 2010 Nucleic Acids Res. pmid:20338881
Kim SH et al. Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. 2010 Breast Cancer Res. pmid:20388208
Kongruttanachok N et al. Replication independent DNA double-strand break retention may prevent genomic instability. 2010 Mol. Cancer pmid:20356374
Terracciano S et al. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. 2010 Bioorg. Med. Chem. pmid:20381359
Zhang LX et al. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. 2010 Am. J. Physiol. Heart Circ. Physiol. pmid:20382965
Kitano A et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. 2010 Mol. Vis. pmid:21203344
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Himaki T et al. Effects of trichostatin A on in vitro development and transgene function in somatic cell nuclear transfer embryos derived from transgenic Clawn miniature pig cells. 2010 Anim. Sci. J. pmid:20887307
Wu P et al. Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. 2010 Cell Death Differ. pmid:19798105
Peidis P et al. HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. 2010 Aging (Albany NY) pmid:21076179
Di Renzo F et al. VPA-related axial skeletal defects and apoptosis: a proposed event cascade. 2010 Reprod. Toxicol. pmid:19850124
Patil V et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. 2010 Bioorg. Med. Chem. pmid:19914074
Choi JH et al. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. 2010 Biochem. Biophys. Res. Commun. pmid:19914212
Dong G et al. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19889954
Bhuiyan MM et al. Production of Sei whale (Balaenoptera borealis) cloned embryos by inter- and intra-species somatic cell nuclear transfer. 2010 J. Reprod. Dev. pmid:19893277
Ellis JK et al. Effect of the histone deacetylase inhibitor trichostatin a on the metabolome of cultured primary hepatocytes. 2010 J. Proteome Res. pmid:19894772
Ninios YP et al. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A. 2010 Leuk. Res. pmid:19782399
Higashiyama R et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. 2010 Mod Rheumatol pmid:19784544
Law AY and Wong CK Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. 2010 Exp. Cell Res. pmid:19786016
Estiu G et al. On the inhibition of histone deacetylase 8. 2010 Bioorg. Med. Chem. pmid:20472442
Kobori A et al. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. 2010 World J. Gastroenterol. pmid:20480520
Kiyokawa S et al. New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. 2010 Bioorg. Med. Chem. pmid:20452226
Barua S and Rege K The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes. 2010 Biomaterials pmid:20452664
Marshall H et al. Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in mice. 2010 BMC Mol. Biol. pmid:20429939
Zhao TC et al. gp-91 mediates histone deacetylase inhibition-induced cardioprotection. 2010 Biochim. Biophys. Acta pmid:20433879
Jeon HW and Lee YM Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. 2010 Mol. Cancer Ther. pmid:20442303